Provided by Tiger Trade Technology Pte. Ltd.

Nuvation Bio, Inc.

5.46
+0.02000.37%
Post-market: 5.35-0.1100-2.01%19:39 EST
Volume:3.28M
Turnover:17.81M
Market Cap:1.87B
PE:-8.53
High:5.62
Open:5.40
Low:5.32
Close:5.44
52wk High:9.75
52wk Low:1.54
Shares:342.83M
Float Shares:231.05M
Volume Ratio:0.81
T/O Rate:1.42%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6400
EPS(LYR):-2.1131
ROE:-52.49%
ROA:-24.82%
PB:5.74
PE(LYR):-2.58

Loading ...

Earning Preview: Nuvation Bio, Inc. this quarter’s revenue is expected to increase by 0%, and institutional views are bullish

Earnings Agent
·
Yesterday

Assessing Nuvation Bio (NUVB) Valuation After Safusidenib Moves Into Phase 3 Astrocytoma Trial

Simply Wall St.
·
Feb 18

Nuvation Bio Inc. to Report Financial Results and Provide Business Update

Reuters
·
Feb 18

Nuvation Bio to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on March 2, 2026

THOMSON REUTERS
·
Feb 18

A Look At Nuvation Bio’s Valuation As Safusidenib SIGMA Trial Advances To Phase 3

Simply Wall St.
·
Feb 11

Nuvation Bio Price Target Maintained With a $11.00/Share by Wedbush

Dow Jones
·
Feb 10

Nuvation Bio Finalizes Protocol Amendment to Change Safusidenib Study From Mid-Stage to Late-Stage Trial

MT Newswires Live
·
Feb 09

Nuvation Bio Launches Phase 3 SIGMA Trial of Safusidenib for IDH1-Mutant Glioma

Reuters
·
Feb 09

Nuvation Bio Announces Pivotal Global Phase 3 Sigma Trial (G203) for Safusidenib in Idh1-Mutant Glioma

THOMSON REUTERS
·
Feb 09

Assessing Nuvation Bio (NUVB) Valuation After The Eisai Taletrectinib Partnership Announcement

Simply Wall St.
·
Jan 25

JonesTrading Sticks to Their Buy Rating for Nuvation Bio (NUVB)

TIPRANKS
·
Jan 23

RBC Raises Price Target on Nuvation Bio to $12 From $9, Keeps Outperform, Speculative Risk

MT Newswires Live
·
Jan 21

Wedbush Remains a Buy on Nuvation Bio (NUVB)

TIPRANKS
·
Jan 13

Nuvation Bio shares attractive on weakness, says B. Riley

TIPRANKS
·
Jan 13

Analysts Offer Insights on Healthcare Companies: Nuvation Bio (NUVB), Mediwound (MDWD) and Argenx Se (ARGX)

TIPRANKS
·
Jan 13

Nuvation Bio Shares Fall After Disappointing Sales Guidance for Lung-Cancer Treatment

Dow Jones
·
Jan 13

Nuvation Bio falls -17.3%

TIPRANKS
·
Jan 12

Nuvation Bio price target lowered to $17 from $18 at H.C. Wainwright

TIPRANKS
·
Jan 12

Nuvation Bio Inc. : H.c. Wainwright Cuts Target Price to $17 From $18

THOMSON REUTERS
·
Jan 12

Nuvation Bio Inc. Highlights Oncology Pipeline and Global Strategy in New Corporate Presentation

Reuters
·
Jan 12